生物标志物 生物标志物
1University of Ghana, Accra, Greater Accra, Ghana.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
基于血液的生物标志物,如神经丝光 (NfL) 和血 (p-tau) 显示出对诊断阿尔茨海默病的前景. 将它们与脑脊液 (CSF) 标记物相结合,为神经退行症监测提供了更容易获得的方法.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物研究 生物标志物研究
- 神经学 神经学
背景情况:
- 神经退行性疾病,如阿尔茨海默病 (AD),对公共卫生构成重大挑战.
- 目前阿尔茨海默病的诊断方法面临局限性,增加了对可靠生物标志物的需求.
- 基于血液的生物标志物为传统的侵入性方法 (如脑脊液 (CSF) 分析和神经成像) 提供了一个非侵入性的,具有成本效益的替代方案.
研究的目的:
- 审查阿尔茨海默病诊断和监测的基于血液的生物标志物的最新进展.
- 评估血神经纤维光 (NfL) 和脑神经纤维NfL在AD中的诊断和预后价值.
- 探索基于血液的生物标志物与已建立的CSF标志物的整合,以改善AD管理.
主要方法:
- 对阿尔茨海默病的基于血液的生物标志物的最新文献进行系统审查.
- 专注于血NfL和CSFNfL作为关键标记物.
- 对诊断准确度和与已确定的AD生物标志物和神经成像数据的相关性进行分析.
主要成果:
- 血和脑液中NfL水平升高与降低的葡萄糖代谢和AD中加速的海马缩相关.
- 血p-tau和Aβ42 / Aβ40比率显示了症状AD的高诊断准确性 (> 85%).
- 在预测认知衰退方面,CSF NfL显示了80%的准确性,而血液NfL可靠地表明神经退行和治疗反应.
结论:
- 基于血液的生物标志物,包括NfL和血p-tau,代表了AD诊断和管理的重大进展.
- 在临床实践和研究中,建议将血液生物标志物与CSF标志物 (T-tau,p-tau,Aβ42,NfL) 结合起来.
- 这些生物标志物为解决AD诊断和护理挑战提供了更容易获得和可靠的方法.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516